96254 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms; Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
An anti-influenza virus derivative and uses thereof
#2IONIZABLE LIPIDOID COMPOSITIONS AND THERAPEUTIC USES THEREOF
#3Monomer for Electrolyte, Electrolyte for Secondary Battery Including the Same, Method of Preparing the Same and Lithium Secondary Battery Including the Same
#4DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS
#5AMP-ACTIVATED PROTEIN KINASE MODULATOR COMPOUNDS AND USES THEREOF
#6DIDEHYDRO-3'-DEOXY-4'-ETHYNYLTHYMIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
#7ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME
#8DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS
#9AMIDE COMPOUND AND USE THEREOF
#10NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES
#11Prodrugs of Thyroid Hormone Analogs, Methods of Making and Methods of Using Thereof
#12ELECTROLYTE AND SECONDARY BATTERY INCLUDING THE SAME
#13Crystalline forms and methods of producing crystalline forms of a compound
#14METHOD OF PREPARING SYMMETRICAL PHOSPHATE-BASED COMPOUND
#15Preparation method of a cyclic phosphonate compound
#16ELECTROLYTE ADDITIVE, ELECTROLYTE FOR BATTERIES INCLUDING ELECTROLYTE ADDITIVE, AND SECONDARY BATTERY INCLUDING ELECTROLYTE
#17Nicotinamide mononucleotide derivatives and their uses
#18RADIO-PROTECTIVE AND CHEMO-PROTECTIVE SUBSTITUTED THIOLS
#19PANTETHEINE DERIVATIVES AND USES THEREOF
#20SECONDARY BATTERY ELECTROLYTE AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME
#21Cyclic pantetheine derivatives and uses thereof
#22URIDINE DIPHOSPHATE DERIVATIVES, PRODRUGS, COMPOSITIONS AND USES THEREOF
#23ANTI-INFLAMMATORY COMPOUNDS AND USES THEREOF
#24Carbacyclic phosphatidic acid compound
#25Nucleotide Analogs
#26AN INDUSTRIAL PROCESS FOR RESOLUTION OF CHLOCYPHOS
#27Preparation method of a cyclic phosphonate compound
#28HETEROCYCLIC THR-B RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREFOR
#29COMPOSITION COMPRISING O-CYCLIC PHYTOSPHINGOSINE-1-PHOSPHATE FOR PREVENTING OR TREATING PARKINSON'S DISEASE
#30A PRODRUG PLATFORM USEFUL TO DELIVER AMINES, AMIDES AND PHENOLS
#31Electrolyte additive for secondary battery, preparation method therefor, and electrolyte composition and secondary battery, which comprise additive
#32ESTERS OF NON- AROMATIC HETEROCYCLIC COMPOUNDS HAVING A NEMATOCIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND USE THEREOF
#33Nucleotide Analogs
#34Nucleotide Analogs
#35METABOLICALLY STABLE PRODRUGS
#36Radio-protective and chemo-protective substituted thiols
#37URIDINE DIPHOSPHATE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
#38Preparation method of a cyclic phosphonate compound
#39COMPOSITION AND FIRE-RETARDANT RESIN COMPOSITION
#40Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#41Crystalline forms and methods of producing crystalline forms of a compound
#42Lithium secondary battery including fluoroethylene carbonate in electrolyte
#43Nicotinamide mononucleotide derivatives and their uses
#44Nucleotide analogs
#45Salts and prodrugs of 1-methyl-d-tryptophan
#46Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same
#47Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same
#48PRODRUGS OF 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES
#49ELECTROLYTE, LITHIUM BATTERY INCLUDING THE SAME, AND METHOD OF MANUFACTURING THE LITHIUM BATTERY
#50Anti-Inflammatory Compounds and Uses Thereof
#51Lithium battery
#52Compound for treating metabolic diseases and preparation method and use thereof
#53Alvocidib prodrugs and their use as protein kinase inhibitors
#54PANTETHEINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGIC DISORDERS
#55Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same
#56Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
#57Anti-Inflammatory Compounds and Uses Thereof
#58Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#59SALTS AND PRODRUGS OF 1-METHYL-D-TRYPTOPHAN
#60Tricyclic sulfones as RORγ modulators
#61Process for the purification of L-α-glycerophosphorylcholine
#62Nucleotide analogs
#63Electrolyte and electrochemical energy storage device
#64Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders
#65Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
#66Phosphate composition
#67Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#68Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same
#69Salts and prodrugs of 1-methyl-D-tryptophan
#70N-heterocyclic phosphines
#71Nucleotide analogs
#72Tricyclic sulfones as RORγ modulators
#73METHOD FOR THE SYNTHESIS OF HETEROCYCLIC HYDROGEN PHOSPHINE OXIDE
#74Metformin derivatives
#75Ionic complex, electrolyte for nonaqueous electrolyte battery, nonaqueous electrolyte battery and ionic complex synthesis method
#76PROCESS OF PREPARING CYCLIC PHOSPHONATE ESTER, CYCLIC PHOSPHONATE ESTER PREPARED THEREFROM AND INDUSTRIAL APPLICATIONS CONTAINING THE SAME
#77Heterocyclic selenamonophosphites protected on a hydroxyl group and processes for preparation thereof
#78Heterocyclic selenabisphosphites and process for preparation thereof
#79Biocompatible, biomimetic ampholyte materials
#80Substituted nucleosides, nucleotides and analogs thereof
#81Fluorescent labeled inhibitors
#82Nucleotide analogs
#83Phenanthroline phosphonic acid derivative and preparation method therefor and application thereof
#84Salts and prodrugs of 1-methyl-D-tryptophan
#85Tricyclic sulfones as RORγ modulators
#86Monophosphite compounds having an ether group
#87Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
#88Uridine diphosphate derivatives, prodrugs, compositions and methods for treating neurodegenerative disorders
#89MONOPHOSPHITES COMPRISING A BENZOPINACOL
#90Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#91Nucleotide analogs
#92Phytosphingosine-1-phosphate derivative, preparation method therefor, and composition for preventing and treating hair loss or for growing hair comprising same
#93NSAIDs derivatives and uses thereof
#94Substituted nucleosides, nucleotides and analogs thereof
#95PHOSPHATE COMPOSITION
#96Organophosphorus compounds for flame retardant polyurethane foams
#97Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#98Nucleotide prodrug compounds and use
#99Water-soluble O-carbonyl phosphoramidate prodrugs for therapeutic administration
#100Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
#101Seriniquinones, melanoma-specific anticancer agents
#102Purified Metal Complex Having Oxalic Acid as Ligand, and Method For Producing Purified Solution of Said Metal Complex in Non-Aqueous Solvent
#103Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
#104Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#105Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
#106Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
#107Non-aqueous electrolyte solution containing phosphonosulfonic acid compound, and lithium secondary battery
#108PURINE MONOPHOSPHATE PRODRUGS FOR TREATMENT OF VIRAL INFECTIONS
#109Substituted phenoxyethyl (isopropyl) acyloxyalkyl phosphonate comprising phosphorusheterocyclic ring and having herbicidal activity, and preparation therefor
#110Methods for treating glaucoma using uridine diphosphate derivatives
#111Compounds, Compositions and Methods for Treating Ocular Conditions
#112Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
#113Phosphorous-containing flame retardants for polyurethane foams
#114STRECKER REAGENTS, THEIR DERIVATIVES, METHODS FOR FORMING THE SAME AND IMPROVED STRECKER REACTION
#115Fluorophosphate surfactants
#116Phosphoric acid ester production method
#117Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
#118Biocompatible, biomimetic ampholyte materials
#119Nonaqueous electrolyte solution, electrochemical element using same, and 1,2-dioxypropane compound used in same
#120ANTI-INFLAMMATORY COMPOUNDS AND USES THEREOF
#121Coupling agents for peptide synthesis
#122Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
#123Processes for production of cyclic alkylene phosphorohalidite and cyclic phosphoric acid ester
#124Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#125Compounds, compositions and methods for treating ocular conditions
#126Phosphorylcholine-based amphiphilic silicones for medical applications
#127Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#128Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#129Cyclic benzimidazole derivatives useful as anti-diabetic agents
#130Fluoroalkyl phosphate compositions
#131PHOSPHORUS-CONTAINING COMPOUNDS AND POLYMERIC COMPOSITIONS COMPRISING SAME
#132Coupling agents for peptide synthesis
#133Deuterated 2, 4-Pyrimidinediamine Compounds and Prodrugs Thereof and Their Uses
#134Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
#135PHOSPHATE ESTER FLAME RETARDANT AND RESINS CONTAINING SAME
#136Polyfluoroether-based phosphates
#137Hydroformylation catalysts
#138Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
#139Phosphorus compounds, use thereof and flame retarding polyester fibers
#140NUCLEOTIDE ANALOGS
#141Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#142Anti-inflammatory compounds and uses thereof
#143Fluoroalkyl phosphate compositions
#144Fluoroalkyl phosphate compositions
#145Polyfluoroether-based phosphates
#146Modulators of Lysophosphatidic Acid (Lpa) Signaling and the Use Thereof
#147Methods and compositions for modulating sphingosine -1- phosphate (S1P) receptor activity
#148Potassium channel modulators
#149Highly active lysophosphatidic acid and method of screening therewith
#150Process for production of amines
#151Method for producing organoacylphosphites
#152Coupling agents for peptide synthesis
#153Stabilization of polyolefins with liquid cyclic phosphites
#154Cytarabine monophosphate prodrugs
#155Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs
#156Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#157Prodrugs of 2,4-pyrimidinediamine compounds and their uses
#158Organophosphorus compound having phosphate-phosphonate bond, and flame-retardant polyester fiber and flame-retardant polyurethane resin composition each containing the same
#159Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
#160Cidofovir peptide conjugates as prodrugs
#161Phosoxophite ligands and use thereof in carbonylation processes
#162Compound having phosphorylcholine group, polymer thereof and process for producing the same
#163Derivatives of 1,3-cyclic propandiol phosphate and their action as cell stimulants
#164Mixtures of chiral monophosphorus compounds used as ligand systems for asymmetric transition metal catalysis
#165Derivatives of cyclic1, 3- propanediol phosphate and their action in differentiation therapy
#166Prodrugs for phosphorus-containing compounds
#167Process for preparing optically active 2,3-dihydrobenzofuran compounds
#168Acyl phosphonate inhibitors of β-lactamases
#169Phosphite stabilizers and methods to preparation and polymer composition thereof
#170Potassium channel modulators